Scott Akamine

Insider Reports History

Entity
Individual
Location
C/O Aeon Biopharma, Inc., 4040 Macarthur Blvd., Suite 260, Newport Beach, CA
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott Akamine:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Chief Legal Officer Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Legal Officer Restricted Stock Units 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Chief Legal Officer Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Scott Akamine

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Jan 19, 2024 1 $0 4 Jan 23, 2024 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 19, 2023 3 -$293K 4 Dec 21, 2023 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Dec 5, 2023 6 -$446K 4 Dec 7, 2023 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 6, 2023 2 $0 4 Feb 8, 2023 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Aug 8, 2022 3 -$268K 4 Aug 9, 2022 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Feb 9, 2022 1 $0 4 Feb 11, 2022 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. Jun 1, 2021 1 $0 4 Jun 3, 2021 Chief Legal Officer
CERE Cerevel Therapeutics Holdings, Inc. May 24, 2021 0 $0 3 May 28, 2021 Chief Legal Officer